TuesdayDec 15, 2020 3:38 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) Marks Proud Milestone, Poised for More Opportunities

InsuraGuest Technologies (TSXV: ISGI), an innovative insurtech leader, is positioned amid new markets on the heels of its approval as a residential surplus lines provider. The company announced this pivotal moment in a press release on Nov. 5, 2020, indicating the license to offer surplus lines casualty and surplus lines property insurance in the state of Utah was granted to its wholly owned subsidiary InsuraGuest Insurance Agency LLC. A recent article discussing this reads, “The licensing will allow InsuraGuest to capitalize on this insurance sector while also opening up more market opportunities to sell additional products and create more revenue…

Continue Reading

TuesdayDec 15, 2020 2:55 pm

Using AI-Powered Models and Drug-Response Data, Predictive Oncology (NASDAQ: POAI) Holds Strong Position in Burgeoning Precision Oncology Industry

Precision oncology leverages the profile of genetic mutations in patients for the purpose of delivering precision drug-based cancer therapy Precision oncology industry forecast to be worth 99.72 billion by 2027 according to recent report POAI applies AI to proprietary data trove, aiding oncologists in personalizing cancer therapies in addition to collaborating with pharmaceutical companies for drug discovery Precision oncology is driven by the profile of genetic mutations in tumors that give practitioners required information to target therapies based off the specific mutations in the patient’s tumor. According to a recent research report, the industry is predicted to be worth 99.72…

Continue Reading

TuesdayDec 15, 2020 2:13 pm

Energy Fuels (NYSE American: UUUU) (TSX: EFR) Has Critical Mineral Portfolio Unlike Any Other

"Energy Fuels will always, first and foremost, be a uranium producer,” says CEO Company is playing it smart with financial stability, scalable production and additional revenue streams that utilize existing facilities Additional revenue streams include rare earth elements, vanadium, uranium recycling, and land clean-up Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company that supplies major nuclear utilities and is making huge moves into the rare earth elements (“REE”) space, is debt free and boasts diverse cash-flow-generating opportunities. In addition to uranium and REEs, the company produces vanadium, recycles uranium-bearing products and participates in land clean-up…

Continue Reading

TuesdayDec 15, 2020 1:58 pm

QualityStocksNewsBreaks – Knightscope Inc.’s K5 ASRs Deploy at Houston Airport

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its deployment at the Houston Airport. According to the update, a pair of Knightscope K5 ASRs are now patrolling 24/7 at the George Bush Intercontinental Airport. In addition to enhancing safety and security, the deployment is planned to include robot-traveler interaction for assistance with vehicle issues such as dead batteries, flat tires and lockouts through two-way intercom call capabilities.  To view the full update, visit https://ibn.fm/g7AZk About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security…

Continue Reading

TuesdayDec 15, 2020 1:41 pm

Cybin Inc. (NEO: CYBN) on Right Path; Johns Hopkins Study Shows Psilocybin Positive Impact on Major Depression

Study published in “JAMA Psychiatry” reveals significant benefits of psilocybin for patients with major depression Most participants reported improvements; half experienced remission after only four weeks As an early entrant in the field, Cybin looks well placed to capitalize on growing traction that psychedelics gain as potential treatment of mental health conditions Only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in depressive symptoms in adults with major depression, according to recent research conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry” (https://ibn.fm/AM1Ww). As a leading life sciences company focused on psychedelic drug development, Cybin…

Continue Reading

TuesdayDec 15, 2020 12:47 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Slated to Present at Leading Investor Forum

Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum ("LSIF"). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor event held quarterly for public and private companies, investors and industry professionals from around the world. The daylong event features company presentations and interactive discussions about the life sciences sector. Pressure BioSciences president and CEO Richard T. Schumacher will be presenting at the forum. His presentation is scheduled for 11 a.m. ET and may include key highlights regarding the company’s three key technology platforms: Pressure Cycling…

Continue Reading

TuesdayDec 15, 2020 12:30 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Successful Deployment of BolaWrap(R)

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced that police in the City of Beaufort, South Carolina safely subdued a subject using the BolaWrap Remote Restraint device. According to the update, the BolaWrap allowed the officers on the scene to take the subject into custody without injury to either themselves or the subject. “As the BolaWrap is carried by more and more agencies, both in the U.S. and internationally, we expect to continue to see examples where our technology enables officers to take subjects into custody safely and humanely. We take great pride in our role…

Continue Reading

TuesdayDec 15, 2020 12:12 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Launches Regulation A+ Offering

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched a Regulation A+ equity crowd-funding campaign. The announcement follows the qualification by the U.S. Securities and Exchange Commission of BRSF’s Form 1-A offering. The intended purpose of the offering is to provide both accredited and non-accredited potential investors an opportunity to support the company in its efforts to more fully introduce its proprietary technologies to the neurology market. Through its Reg A+ offering, Brain Scientific will sell units at $9 each, with a minimum investment of $500. The units are comprised of five  shares of common stock and one…

Continue Reading

TuesdayDec 15, 2020 12:03 pm

QualityStocksNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) to Present at LD Micro Main Event

Siyata Mobile (NASDAQ: SYTA, SYTAW), a business-to-business (“B2B”) global vendor of next-generation cellular solutions, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, Dec. 15, 2020. SYTA’s VP of Corporate Development, Daniel Kim, is scheduled to present at 9:20 a.m. ET to a live, virtual audience. The Main Event features a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts. Interested parties should visit https://ibn.fm/s8t2W to register for and access the event. To view the full…

Continue Reading

TuesdayDec 15, 2020 11:49 am

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Subsidiary Enters Strategic Agreement with Key Account

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary BergaMet NA has entered into an exclusive performance-driven agreement with Xymogen(R) to purchase BergaMet’s Citrus Bergamot SuperFruit(TM). According to the update, the agreement has been three years in development, and Xymogen is now selling and distributing proprietary formulations of BergaCor(TM) and BergaCorPlus(TM) to its 20,000- plus medical doctor network. “This partnership with Xymogen exemplifies Bergamet NA’s strategic B2B goal of a continued growth strategy,” said…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered